Benzinga | Nov 15, 2021 10:45AM EST

Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $28

Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $26 to $28.